PMC:7534795 / 59954-60162 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T239","span":{"begin":100,"end":105},"obj":"Body_part"},{"id":"T240","span":{"begin":192,"end":197},"obj":"Body_part"}],"attributes":[{"id":"A239","pred":"fma_id","subj":"T239","obj":"http://purl.org/sig/ont/fma/fma7088"},{"id":"A240","pred":"fma_id","subj":"T240","obj":"http://purl.org/sig/ont/fma/fma7088"}],"text":"(Mozaffarian et al., 2013). Currently, the intake of n-3 PUFAs is still recommended by the American Heart Association to prevent clinical CVD episodes in individuals with predominant coronary heart disease, s"}

{"project":"LitCovid-PD-UBERON","denotations":[{"id":"T85","span":{"begin":100,"end":105},"obj":"Body_part"},{"id":"T86","span":{"begin":192,"end":197},"obj":"Body_part"}],"attributes":[{"id":"A85","pred":"uberon_id","subj":"T85","obj":"http://purl.obolibrary.org/obo/UBERON_0000948"},{"id":"A86","pred":"uberon_id","subj":"T86","obj":"http://purl.obolibrary.org/obo/UBERON_0000948"}],"text":"(Mozaffarian et al., 2013). Currently, the intake of n-3 PUFAs is still recommended by the American Heart Association to prevent clinical CVD episodes in individuals with predominant coronary heart disease, s"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T410","span":{"begin":183,"end":205},"obj":"Disease"},{"id":"T411","span":{"begin":192,"end":205},"obj":"Disease"}],"attributes":[{"id":"A410","pred":"mondo_id","subj":"T410","obj":"http://purl.obolibrary.org/obo/MONDO_0005010"},{"id":"A411","pred":"mondo_id","subj":"T411","obj":"http://purl.obolibrary.org/obo/MONDO_0005267"}],"text":"(Mozaffarian et al., 2013). Currently, the intake of n-3 PUFAs is still recommended by the American Heart Association to prevent clinical CVD episodes in individuals with predominant coronary heart disease, s"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T352","span":{"begin":100,"end":105},"obj":"http://purl.obolibrary.org/obo/UBERON_0000948"},{"id":"T353","span":{"begin":100,"end":105},"obj":"http://purl.obolibrary.org/obo/UBERON_0007100"},{"id":"T354","span":{"begin":100,"end":105},"obj":"http://purl.obolibrary.org/obo/UBERON_0015228"},{"id":"T355","span":{"begin":100,"end":105},"obj":"http://www.ebi.ac.uk/efo/EFO_0000815"},{"id":"T356","span":{"begin":192,"end":197},"obj":"http://purl.obolibrary.org/obo/UBERON_0000948"},{"id":"T357","span":{"begin":192,"end":197},"obj":"http://purl.obolibrary.org/obo/UBERON_0007100"},{"id":"T358","span":{"begin":192,"end":197},"obj":"http://purl.obolibrary.org/obo/UBERON_0015228"},{"id":"T359","span":{"begin":192,"end":197},"obj":"http://www.ebi.ac.uk/efo/EFO_0000815"}],"text":"(Mozaffarian et al., 2013). Currently, the intake of n-3 PUFAs is still recommended by the American Heart Association to prevent clinical CVD episodes in individuals with predominant coronary heart disease, s"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T42008","span":{"begin":57,"end":62},"obj":"Chemical"}],"attributes":[{"id":"A65323","pred":"chebi_id","subj":"T42008","obj":"http://purl.obolibrary.org/obo/CHEBI_26208"}],"text":"(Mozaffarian et al., 2013). Currently, the intake of n-3 PUFAs is still recommended by the American Heart Association to prevent clinical CVD episodes in individuals with predominant coronary heart disease, s"}

{"project":"2_test","denotations":[{"id":"33031856-23546563-84038927","span":{"begin":21,"end":25},"obj":"23546563"}],"text":"(Mozaffarian et al., 2013). Currently, the intake of n-3 PUFAs is still recommended by the American Heart Association to prevent clinical CVD episodes in individuals with predominant coronary heart disease, s"}

{"project":"LitCovid-PubTator","denotations":[{"id":"1788","span":{"begin":138,"end":141},"obj":"Disease"},{"id":"1789","span":{"begin":183,"end":205},"obj":"Disease"}],"attributes":[{"id":"A1788","pred":"tao:has_database_id","subj":"1788","obj":"MESH:D002318"},{"id":"A1789","pred":"tao:has_database_id","subj":"1789","obj":"MESH:D003324"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"(Mozaffarian et al., 2013). Currently, the intake of n-3 PUFAs is still recommended by the American Heart Association to prevent clinical CVD episodes in individuals with predominant coronary heart disease, s"}